GRÜNENTHAL STRENGTHENS ITS GENETIC MEDICINE CAPABILITIES AND JOINS THE CLUSTER FOR NUCLEIC ACID THERAPEUTICS MUNICH

Contributed by: News Aktuell

Issued by news aktuell/OTS on behalf of Grünenthal Group

Logo

Tags

Medical profession

Joint venture

More Like This

GRÜNENTHAL TAKES FULL OWNERSHIP OF GRÜNENTHAL MEDS, THE JOINT VENTURE ESTABLISHED WITH KYOWA KIRIN FOR ITS ESTABLISHED MEDICINES BRANDS

GRÜNENTHAL'S PROPRIETARY NAV 1.8 INHIBITOR ENTERS CLINICAL DEVELOPMENT

SK pharmteco and Genethon Showcase French Manufacturing Strength Behind Pivotal DMD Gene Therapy Program

PR Newswire associated0

Tsingke Biotech Hosts Shanghai Salon on Oligonucleotide Drugs, Spotlighting Next-Gen RNA Therapeutics

MAREN THUROW STARTS AS NEW HEAD GLOBAL COMMUNICATIONS AT GRÜNENTHAL

PR Newswire associated0

Chromatin Bioscience, Mediphage Bioceuticals, and Entos Pharmaceuticals, collaborate on Genetic Medicines Project with support from UKRI Innovate UK and Canadian R&D Funding

GRÜNENTHAL PRO IS JOINING SHL MEDICAL'S ALLIANCE PARTNERSHIP NETWORK TO OFFER FINAL ASSEMBLY SERVICE FOR MOLLY® AUTOINJECTORS

PR Newswire associated0

Tsingke Biotech Hosts 2025 Small Nucleic Acid Therapeutics Roundtable in Beijing